Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia-Reference-Cited by-同舟云学术

Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia

Published:2015-01 Issue:1-2 Volume:225 Page:58-63
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

El Kissi Yousri,Samoud Samar,Mtiraoui Ahlem,Letaief Leila,Hannachi Neila,Ayachi Mouna,Ali Bechir Ben Hadj,Boukadida Jalel

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference61 articles.

1. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatric Association,2000

2. Negative symptoms in schizophrenia;Andreasen;Archives of General Psychiatry,1982

3. Scale for the Assessment of Negative Symptoms (SANS);Andreasen,1983

4. Scale for the Assessment of Positive Symptoms (SAPS);Andreasen,1984

5. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia;Avgustin;Croatian Medical Journal,2005

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B Cell-activating factor (BAFF): A promising trans-nosographic biomarker of inflammation and autoimmunity in bipolar disorder and schizophrenia;Brain, Behavior, and Immunity;2024-10

2. The Interrelationships between Cytokines and Schizophrenia: A Systematic Review;International Journal of Molecular Sciences;2024-08-03

3. Altered serum interleukin-17A and interleukin-23A levels may be associated with the pathophysiology and development of generalized anxiety disorder;Scientific Reports;2024-07-02

4. The associations of psychopathology and metabolic parameters with serum bilirubin levels in patients with acute-episode and drug-free schizophrenia: a 5-year retrospective study using an electronic medical record system;BMC Psychiatry;2024-05-29

5. Association Between Maternal Mood Disorders and Schizophrenia and the Risk of Type 1 Diabetes in Offspring: A Nationwide Cohort Study;Neuropsychiatric Disease and Treatment;2023-11